tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN
US Market
REGN
Regeneron
RESEARCH TOOLSreports

Regeneron (REGN) Stock News & Sentiment

5,169 Followers
Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth
Premium
Company Announcements
Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth
12d ago
REGN
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
Premium
Market News
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
24d ago
DIA
PDD
Regeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease
Premium
Company Announcements
Regeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease
27d ago
SNY
REGN
Dupilumab Study Tracks Mental Health Benefits in Atopic Dermatitis Patients Across Gulf Countries
Premium
Company Announcements
Dupilumab Study Tracks Mental Health Benefits in Atopic Dermatitis Patients Across Gulf Countries
1M ago
SNY
REGN
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
Premium
Company Announcements
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
1M ago
REGN
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
Premium
Market News
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
1M ago
NEM
SNY
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
Premium
Market News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
2M ago
BIB
CRBU
More REGN News >

REGN News on the Web

Regeneron price target raised to $796 from $769 at Morgan Stanley
TipRanks News
Neutral
Regeneron (REGN) Gets a Hold from Morgan Stanley
TipRanks News
Neutral
Piper Sandler Reaffirms Their Buy Rating on Regeneron (REGN)
TipRanks News
Bullish
REGN or ILMN: Which Is the Better Value Stock Right Now?
Zacks
Bullish
A catalyst-rich biotech may be poised to resume its recovery. Use options to take advantage
CNBC
Neutral
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Regeneron (REGN)
TipRanks News
Neutral
Regeneron price target lowered to $921 from $925 at Bernstein
TipRanks News
Neutral
Regeneron price target raised to $779 from $765 at RBC Capital
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
REGN
Sector Average
Media Buzz
This Week12 articles
Weekly Average12.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?
12 articles about REGN were published this week. In an average week, 12.5 articles are published.
    What is REGN’s weekly average amount of articles?
    In an average week, 12.5 articles about REGN are published.
      What is REGN’s News Sentiment?
      100% of articles about REGN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week